RPAM
Rhenman & Partners Asset Management’s TG Therapeutics TGTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.14M | Sell |
115,000
-62,500
| -35% | -$2.25M | 0.52% | 56 |
|
|
2025
Q1 | $7M | Sell |
177,500
-85,000
| -32% | -$3.35M | 0.8% | 39 |
|
|
2024
Q4 | $7.9M | Buy |
262,500
+91,000
| +53% | +$2.74M | 0.81% | 46 |
|
|
2024
Q3 | $4.01M | Sell |
171,500
-42,000
| -20% | -$982K | 0.33% | 72 |
|
|
2024
Q2 | $3.8M | Buy |
213,500
+90,000
| +73% | +$1.6M | 0.36% | 64 |
|
|
2024
Q1 | $1.88M | Sell |
123,500
-36,500
| -23% | -$555K | 0.18% | 79 |
|
|
2023
Q4 | $2.73M | Hold |
160,000
| – | – | 0.27% | 69 |
|
|
2023
Q3 | $1.34M | Buy |
160,000
+105,000
| +191% | +$878K | 0.14% | 79 |
|
|
2023
Q2 | $1.37M | Buy |
+55,000
| New | +$1.37M | 0.14% | 79 |
|